Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks

Elisabetta Degasperi, S. Fagiuoli, Andrea Lombardi et al.|Digestive and Liver Disease|2019

Cited by 1